See LEGEND for key to shading and symbols.
Subject Area - PHAR Term - Semester 2 2015
PHAR2011 | PHAR2211 | PHAR3101 | PHAR3202 | PHAR3306 | PHAR9103 |
PHAR9104 | PHAR9108 | PHAR9111 | PHAR9112 | PHAR9116 | PHAR9117 |
PHAR9120 | PHAR9128 |
Data is correct as at Fri Jun 5 16:09:15 AEST 2015
Comp | Sect | Class | Type | Status | Enr/Cap | % Full | Times (weeks, Location) - default 1hour |
PHAR2011 | Introductory Pharmacology and | ||||||
LAB | M10A | 3505 | Enr | Full | 100/100 | 100% | Mon 10-13 (w1-2,4,6,8,10, Wurth 115) |
LAB | M10B | 3506 | Enr | Open | 87/100 | 87% | Mon 10-13 (w1,3,5,7,9,11, Wurth 115) |
LAB | M14A | 3507 | Enr | Open | 36/75 | 48% | Mon 14-17 (w1,3,5,7,9,11, Wurth 115) |
LEC | A | 3504 | Rel | Open | 223/300 | 74% | Wed 13 (w1-9,10-12, Science Th); Wed 14 (w1-9,10-12, Science Th) Comb/w PHAR2211 |
TUT | F10A | 3508 | Rel | Full | 49/49 | 100% | Fri 10 (w2-9,10-13, Mat 123) |
TUT | F10B | 3509 | Rel | Full | 44/44 | 100% | Fri 10 (w2-9,10-13, Mat 107) |
TUT | W11A | 3510 | Rel | Open | 39/50 | 78% | Wed 11 (w2-9,10-13, RedC 1040) |
TUT | W11B | 3511 | Rel | Open | 38/45 | 84% | Wed 11 (w2-9,10-13, MorvB G6) |
TUT | W17A | 3512 | Rel | Open | 39/40 | 98% | Wed 17 (w2-9,10-13, Mat 107) |
TUT | W17B | 3513 | Rel | Open | 14/25 | 56% | Wed 17 (w2-9,10-13, Mat 123) |
PHAR2211 | Pharmacology for HESC | ||||||
LAB | M14A | 6470 | Enr | Open | 66/85 | 78% | Mon 14-17 (w1-2,4,6,8,10, Wurth 115) |
LEC | A | 6469 | Rel | Open | 66/85 | 78% | Wed 13 (w1-9,10-12, Science Th); Wed 14 (w1-9,10-12, Science Th) Comb/w PHAR2011 |
SEM | W15A | 9619 | Rel | Open | 66/84 | 79% | Wed 15-17 (w2-9,10-13, CLB 3) |
PHAR3101 | Drug Discovery, Design & Devel | ||||||
LAB | W14A | 4649 | Enr | Open | 50/60 | 83% | Wed 14-17 (w2-9,10-13, Wurth 115) |
LEC | A | 4648 | Rel | Open | 50/60 | 83% | Tue 13 (w1-9,10-12, MathewsThC); Thu 10 (w1-9,10-12, MathewsThC) |
TUT | H11A | 4650 | Rel | Open | 22/30 | 73% | Thu 11 (w2-9,10-13, Mat 307) |
TUT | H12A | 4651 | Rel | Open | 28/30 | 93% | Thu 12 (w2-9,10-13, Mat 307) |
PHAR3202 | Neuropharmacology | ||||||
LAB | H10A | 6074 | Enr | Open | 38/50 | 76% | Thu 10-13 (w2-9,10-13, Wurth 120) |
LAB | H14A | 6075 | Enr | Open | 49/50 | 98% | Thu 14-17 (w2-9,10-13, Wurth 120) |
LEC | A | 6073 | Rel | Open | 87/100 | 87% | Mon 10 (w1-9,10-12, MathewsThC); Wed 17 (w1-9,10-12, MathewsThC) |
TUT | M13A | 6076 | Rel | Full | 35/35 | 100% | Mon 13 (w1-9,10-12, Mat 232) |
TUT | M14A | 6077 | Rel | Full | 35/35 | 100% | Mon 14 (w1-9,10-12, Mat 130) |
TUT | M15A | 6078 | Rel | Open | 17/35 | 49% | Mon 15 (w1-9,10-12, Mat 130) |
PHAR3306 | Pharmacology for Optometry | ||||||
LAB | H14A | 6080 | Enr | Open | 96/98 | 98% | Thu 14 (w2, WurthG07); Thu 14-17 (w8, Wurth 115); Thu 14-17 (w3,5,7,9,11, WurthG07) |
LEC | A | 6079 | Rel | Open | 96/98 | 98% | Mon 14 (w1-9,10-12, CLB 2); Wed 16-18 (w1-9,10-12, WurthLG03) |
TUT | H14B | 6081 | Rel | Full | 32/32 | 100% | Thu 14 (w4,6,10,12, JGoodsLG19) |
TUT | H15A | 6082 | Rel | Full | 34/34 | 100% | Thu 15 (w4,6,10,12, JGoodsLG19) |
TUT | H16A | 6083 | Rel | Open | 30/34 | 88% | Thu 16 (w4,6,10,12, ElecEng222) |
PHAR9103 | Biostatistics and Trial Design | ||||||
DST | 03 | 1482 | Enr | Open | 1/20 | 5% | |
PHAR9104 | Legal/Regulatory Devlp of Med | ||||||
DST | 04 | 1483 | Enr | Open | 5/30 | 17% | |
PHAR9108 | Therapeutic Basis of Drug Use | ||||||
DST | 08 | 1488 | Enr | Open | 4/30 | 13% | |
PHAR9111 | Pharmaceutical Formulation 2 | ||||||
DST | 11 | 1486 | Enr | Open* | 0/30 | 0% | |
PHAR9112 | Advanced Pharmacokinetics | ||||||
DST | 12 | 9170 | Enr | Open | 2/20 | 10% | |
PHAR9116 | Advanced Clinical Trials Mgmt | ||||||
DST | 16 | 1485 | Enr | Open | 5/30 | 17% | |
PHAR9117 | Cancer Therapeutics | ||||||
DST | 17 | 9164 | Enr | Open | 8/20 | 40% | |
PHAR9120 | Clinical Development of Med | ||||||
DST | 20 | 1487 | Enr | Open | 6/30 | 20% | |
PHAR9128 | R & D | ||||||
DST | 28 | 1484 | Enr | Open | 7/30 | 23% | |
^ top ^ | |||||||
LEGEND | |||||||
* This class requires consent. Students cannot self-enrol. | |||||||
# Timetable clash allowed. | |||||||
/odd Runs in odd weeks only. /even Runs in even weeks only. | |||||||
Comb/w Jointly taught with corresponding class(es) for specified course(s). Capacity shown is effective capacity. | |||||||
Effective capacity is the class capacity less any places taken by students in the other jointly-taught classes. | |||||||
[ ] Class capacity where different from effective capacity. | |||||||
Shaded cells: | LEC | Activity different from previous | |||||
Stop | Status is Stop Further Enrolment, Tentative, Closed or Cancelled | ||||||
100% | Class is full (> 100% means capacity is exceeded) | ||||||
80% | Class is nearly full (80% or more) | ||||||
50% | Class is half full | ||||||
0% | Class is less than half full | ||||||
UNSW Sydney NSW 2052, Australia Telephone: (within Aust.) 02 9385 1000, (International) +61 2 9385 1000 CRICOS Provider Code 00098G Authorised by the Deputy Vice Chancellor (Academic) and RegistrarPrivacy Statement Copyright Disclaimer |